Cargando…
Direct acute tubular damage contributes to Shigatoxin-mediated kidney failure
The pathogenesis and therapy of Shigatoxin 2 (Stx2)-mediated kidney failure remain controversial. Our aim was to test whether, during an infection with Stx2-producing E. coli (STEC), Stx2 exerts direct effects on renal tubular epithelium and thereby possibly contributes to acute renal failure. Mice...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282478/ https://www.ncbi.nlm.nih.gov/pubmed/24909663 http://dx.doi.org/10.1002/path.4388 |
_version_ | 1782351143171522560 |
---|---|
author | Porubsky, Stefan Federico, Giuseppina Müthing, Johannes Jennemann, Richard Gretz, Norbert Büttner, Stefan Obermüller, Nicholas Jung, Oliver Hauser, Ingeborg A Gröne, Elisabeth Geiger, Helmut Gröne, Hermann-Josef Betz, Christoph |
author_facet | Porubsky, Stefan Federico, Giuseppina Müthing, Johannes Jennemann, Richard Gretz, Norbert Büttner, Stefan Obermüller, Nicholas Jung, Oliver Hauser, Ingeborg A Gröne, Elisabeth Geiger, Helmut Gröne, Hermann-Josef Betz, Christoph |
author_sort | Porubsky, Stefan |
collection | PubMed |
description | The pathogenesis and therapy of Shigatoxin 2 (Stx2)-mediated kidney failure remain controversial. Our aim was to test whether, during an infection with Stx2-producing E. coli (STEC), Stx2 exerts direct effects on renal tubular epithelium and thereby possibly contributes to acute renal failure. Mice represent a suitable model because they, like humans, express the Stx2-receptor Gb3 in the tubular epithelium but, in contrast to humans, not in glomerular endothelia, and are thus free of glomerular thrombotic microangiopathy (TMA). In wild-type mice, Stx2 caused acute tubular dysfunction with consequent electrolyte disturbance, which was most likely the cause of death. Tubule-specific depletion of Gb3 protected the mice from acute renal failure. In vitro, Stx2 induced secretion of proinflammatory cytokines and apoptosis in human tubular epithelial cells, thus implicating a direct effect of Stx2 on the tubular epithelium. To correlate these results to human disease, kidney biopsies and outcome were analysed in patients with Stx2-associated kidney failure (n = 11, aged 22–44 years). The majority of kidney biopsies showed different stages of an ongoing TMA; however, no glomerular complement activation could be demonstrated. All biopsies, including those without TMA, showed severe acute tubular damage. Due to these findings, patients were treated with supportive therapy without complement-inhibiting antibodies (eculizumab) or immunoadsorption. Despite the severity of the initial disease [creatinine 6.34 (1.31–17.60) mg/dl, lactate dehydrogenase 1944 (753–2792) U/l, platelets 33 (19–124)/nl and haemoglobin 6.2 (5.2–7.8) g/dl; median (range)], all patients were discharged after 33 (range 19–43) days with no neurological symptoms and no dialysis requirement [creatinine 1.39 (range 0.84–2.86) mg/dl]. The creatinine decreased further to 0.90 (range 0.66–1.27) mg/dl after 24 months. Based on these data, one may surmise that acute tubular damage represents a separate pathophysiological mechanism, importantly contributing to Stx2-mediated acute kidney failure. Specifically in young adults, an excellent outcome can be achieved by supportive therapy only. © 2014 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland. |
format | Online Article Text |
id | pubmed-4282478 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | John Wiley & Sons, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-42824782015-01-15 Direct acute tubular damage contributes to Shigatoxin-mediated kidney failure Porubsky, Stefan Federico, Giuseppina Müthing, Johannes Jennemann, Richard Gretz, Norbert Büttner, Stefan Obermüller, Nicholas Jung, Oliver Hauser, Ingeborg A Gröne, Elisabeth Geiger, Helmut Gröne, Hermann-Josef Betz, Christoph J Pathol Original Papers The pathogenesis and therapy of Shigatoxin 2 (Stx2)-mediated kidney failure remain controversial. Our aim was to test whether, during an infection with Stx2-producing E. coli (STEC), Stx2 exerts direct effects on renal tubular epithelium and thereby possibly contributes to acute renal failure. Mice represent a suitable model because they, like humans, express the Stx2-receptor Gb3 in the tubular epithelium but, in contrast to humans, not in glomerular endothelia, and are thus free of glomerular thrombotic microangiopathy (TMA). In wild-type mice, Stx2 caused acute tubular dysfunction with consequent electrolyte disturbance, which was most likely the cause of death. Tubule-specific depletion of Gb3 protected the mice from acute renal failure. In vitro, Stx2 induced secretion of proinflammatory cytokines and apoptosis in human tubular epithelial cells, thus implicating a direct effect of Stx2 on the tubular epithelium. To correlate these results to human disease, kidney biopsies and outcome were analysed in patients with Stx2-associated kidney failure (n = 11, aged 22–44 years). The majority of kidney biopsies showed different stages of an ongoing TMA; however, no glomerular complement activation could be demonstrated. All biopsies, including those without TMA, showed severe acute tubular damage. Due to these findings, patients were treated with supportive therapy without complement-inhibiting antibodies (eculizumab) or immunoadsorption. Despite the severity of the initial disease [creatinine 6.34 (1.31–17.60) mg/dl, lactate dehydrogenase 1944 (753–2792) U/l, platelets 33 (19–124)/nl and haemoglobin 6.2 (5.2–7.8) g/dl; median (range)], all patients were discharged after 33 (range 19–43) days with no neurological symptoms and no dialysis requirement [creatinine 1.39 (range 0.84–2.86) mg/dl]. The creatinine decreased further to 0.90 (range 0.66–1.27) mg/dl after 24 months. Based on these data, one may surmise that acute tubular damage represents a separate pathophysiological mechanism, importantly contributing to Stx2-mediated acute kidney failure. Specifically in young adults, an excellent outcome can be achieved by supportive therapy only. © 2014 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland. John Wiley & Sons, Ltd 2014-09 2014-07-25 /pmc/articles/PMC4282478/ /pubmed/24909663 http://dx.doi.org/10.1002/path.4388 Text en © 2014 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the orignal work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Original Papers Porubsky, Stefan Federico, Giuseppina Müthing, Johannes Jennemann, Richard Gretz, Norbert Büttner, Stefan Obermüller, Nicholas Jung, Oliver Hauser, Ingeborg A Gröne, Elisabeth Geiger, Helmut Gröne, Hermann-Josef Betz, Christoph Direct acute tubular damage contributes to Shigatoxin-mediated kidney failure |
title | Direct acute tubular damage contributes to Shigatoxin-mediated kidney failure |
title_full | Direct acute tubular damage contributes to Shigatoxin-mediated kidney failure |
title_fullStr | Direct acute tubular damage contributes to Shigatoxin-mediated kidney failure |
title_full_unstemmed | Direct acute tubular damage contributes to Shigatoxin-mediated kidney failure |
title_short | Direct acute tubular damage contributes to Shigatoxin-mediated kidney failure |
title_sort | direct acute tubular damage contributes to shigatoxin-mediated kidney failure |
topic | Original Papers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282478/ https://www.ncbi.nlm.nih.gov/pubmed/24909663 http://dx.doi.org/10.1002/path.4388 |
work_keys_str_mv | AT porubskystefan directacutetubulardamagecontributestoshigatoxinmediatedkidneyfailure AT federicogiuseppina directacutetubulardamagecontributestoshigatoxinmediatedkidneyfailure AT muthingjohannes directacutetubulardamagecontributestoshigatoxinmediatedkidneyfailure AT jennemannrichard directacutetubulardamagecontributestoshigatoxinmediatedkidneyfailure AT gretznorbert directacutetubulardamagecontributestoshigatoxinmediatedkidneyfailure AT buttnerstefan directacutetubulardamagecontributestoshigatoxinmediatedkidneyfailure AT obermullernicholas directacutetubulardamagecontributestoshigatoxinmediatedkidneyfailure AT jungoliver directacutetubulardamagecontributestoshigatoxinmediatedkidneyfailure AT hauseringeborga directacutetubulardamagecontributestoshigatoxinmediatedkidneyfailure AT groneelisabeth directacutetubulardamagecontributestoshigatoxinmediatedkidneyfailure AT geigerhelmut directacutetubulardamagecontributestoshigatoxinmediatedkidneyfailure AT gronehermannjosef directacutetubulardamagecontributestoshigatoxinmediatedkidneyfailure AT betzchristoph directacutetubulardamagecontributestoshigatoxinmediatedkidneyfailure |